Richard Koya, MD, PhD of Roswell Park Cancer Institute discusses how the persistency of t-cell receptors against cancer can be achieved. He argues with this data, there will be more effective treatments for cancer and lower chances of relapse. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Promising Data Shows Persistency of T-Cells Against Cancer Can Be Achieved
